Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

ASCO 2026: Previewing Updates on ADCs and SERDs in mBC

Dr Elizabeth Sakach expects ASCO 2026 data on ADCs and SERDs in metastatic breast cancer will focus on frontline use, sequencing, and socioeconomics.

Conference MDAngle: ASCO 2026 Early Breast Cancer

Insights from ASCO 2026, including anticipated presentations, key takeaways, and how emerging research in early breast cancer is poised to reshape treatment strategies

Transition From Pediatric to Adult HIV Care: Smooth for All?

Most youth living with HIV transition from pediatric to adult care, but fewer than half maintain timely and ongoing care, a South Carolina study finds.

PRECISE Score Predicts Prostate Cancer Progression

A multicentre validation of the PRECISE scoring system for prostate MRI shows that it effectively predicts disease progression and can reduce unnecessary biopsies for patients on active surveillance.

Insomnia Tied to Greater Symptom Burden in IBS

Insomnia affects a substantial subset of patients with irritable bowel syndrome and is linked to a higher burden of somatic and psychological symptoms and impaired quality of life.

Few Pediatric Cancer Drugs Reach Phase 3 or Approval

Fewer than one out of five anticancer drugs that entered pediatric clinical testing advanced to phase 3 trials, and fewer still earned pediatric regulatory approval, according to recent analysis.

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Latest News

Dr Elizabeth Sakach expects ASCO 2026 data on ADCs and SERDs in metastatic breast cancer will focus on frontline use, sequencing, and socioeconomics.

Insights from ASCO 2026, including anticipated presentations, key takeaways, and how emerging research in early breast cancer is poised to reshape treatment strategies

Most youth living with HIV transition from pediatric to adult care, but fewer than half maintain timely and ongoing care, a South Carolina study finds.

A multicentre validation of the PRECISE scoring system for prostate MRI shows that it effectively predicts disease progression and can reduce unnecessary biopsies for patients on active surveillance.

Insomnia affects a substantial subset of patients with irritable bowel syndrome and is linked to a higher burden of somatic and psychological symptoms and impaired quality of life.

Fewer than one out of five anticancer drugs that entered pediatric clinical testing advanced to phase 3 trials, and fewer still earned pediatric regulatory approval, according to recent analysis.

News All Time

On the Horizon: Dry Eye in Focus at ARVO 2026

A trio of studies from the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting show the potential of several emerging treatments for dry eye disease.

Two SMA Drugs Move to Routine NHS Funding

NICE has recommended routine NHS access to nusinersen and risdiplam for spinal muscular atrophy, ending time-limited managed access schemes in place since 2019.

Why Epilepsy Transition Matters in Young People

A structured transition from paediatric to adult epilepsy care is linked to improved seizure control between ages of 17 and 20 years in young people with epilepsy.

Neighborhood Factors Affect Timing of Dementia Diagnosis

Black and Hispanic older adults are less likely than White older adults to receive timely diagnosis of dementia, with lower levels of education explaining a substantial proportion of this disparity.

Depression, Not Pain, Drives Costs in Neuromyelitis Optica

In patients with neuromyelitis optica spectrum disorders, depression rather than pain shows the strongest association with healthcare costs.

Early-Onset Colorectal Cancer Risk Factors Identified

Two new studies have identified risk factors that may be associated with the increasing incidence of colorectal cancer among younger Americans.

Streeting Weighs Quitting as NHS Reform Bill Unveiled

Labour turmoil threatens to overshadow NHS modernisation bill as Health Secretary Wes Streeting mulls leadership bid.

At-Home, Mail-In Finger-Stick Test Flags AD Biomarkers

An at-home, mail-in, finger-stick blood test detected Alzheimer’s-related biomarkers associated with cognitive performance in older adults, raising the possibility of large-scale dementia risk screening outside clinical settings.

EU Agrees Draft Deal to Tackle Essential Medicine Shortages

European Union lawmakers and member states reached a provisional deal on Tuesday to strengthen the bloc's supply ⁠of essential medicines by boosting domestic production and...

Free Birth Movement Presents Ethical Quandary: Ethicist

Art Caplan discusses the medical ethics involved in a free birth that went terribly wrong.

Obesity Management After Unsuccessful Dieting

A 45-year-old woman with a BMI of 38 kg/m2 presents with obesity despite lifestyle modifications. This case discussion on obesity highlights management strategies with novel incretin-based therapies.

The Ivermectin Paradox in Oncology

Dr Arturo Loaiza-Bonilla examines the gap between ivermectin’s lab data and clinical reality, offering a guide to debunking ‘miracle cure’ myths while maintaining patient trust.

TikTok and the Squatty Potty: Seeking Help for Constipation

Two studies take different approaches to improving constipation, one examining the influence of TikTok and the other examining the effect of physical positioning.

Peptides Lack Reliable Safety Information, Watchdog Warns

As peptides for wellness surge in popularity, two safety groups warn many users may be injecting unapproved substances with little evidence they are safe or effective.

Adjunctive Antipsychotics for Major Depression Ranked

A new meta-analysis shows meaningful differences among FDA-approved antipsychotic adjuncts for MDD, with lumateperone showing the strongest efficacy and aripiprazole the best overall acceptability.

FDA Expands Vyvgart Approval to All Adults With gMG

The label expansion will include adults with AChR-Ab-negative gMG, making efgartigimod the first and only approved treatment for all serotypes of the rare neuromuscular disease.